Who owns Biogen Idec?

Key details on Biogen Idec (Ticker: BIIB)

Who owns Biogen Idec?

Is BIIB a good stock to own? Find out who bought Biogen Idec, who sold Biogen Idec (BIIB) stock, and who holds a large position in Biogen Idec.

Fund Name Number of Shares Share Valuation As Of
FMR 19.00M $6.29B Sept. 30, 2014
PRIMECAP Management Company 17.17M $5.83B Dec. 31, 2014
Icahn Capital 12.86M $943.81M March 31, 2011
Vanguard 12.73M $4.32B Dec. 31, 2014
T. Rowe Price Associates 12.18M $4.13B Dec. 31, 2014
Schroder Investment Management 11.19M $2.69B Sept. 30, 2013
STATE STREET CORPORATION 10.11M $3.43B Dec. 31, 2014
ClearBridge Advisors 8.23M $2.79B Dec. 31, 2014
Capital Research Global Investors^ 8.20M $2.59B June 30, 2014
JPMORGAN CHASE & CO 6.97M $2.37B Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 6.27M $2.13B Dec. 31, 2014
Ameriprise Financial 5.67M $818.02M June 30, 2012
Jennison Associates 5.62M $1.91B Dec. 31, 2014
Wellington Management Company 5.16M $769.35M Sept. 30, 2012
Marsico Capital Management 5.11M $750.01M Dec. 31, 2012
Sands Capital Management 4.97M $1.69B Dec. 31, 2014

Who sold Biogen Idec?

Fund Name Date Sold Number of Shares Sold Share Valuation
GOLDMAN SACHS March 31, 2011 5.99M $440.41M